0001104659-14-057230.txt : 20140806
0001104659-14-057230.hdr.sgml : 20140806
20140806090347
ACCESSION NUMBER: 0001104659-14-057230
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140805
FILED AS OF DATE: 20140806
DATE AS OF CHANGE: 20140806
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MARINUS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001267813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 142 TEMPLE STREET, SUITE 205
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-315-0566
MAIL ADDRESS:
STREET 1: 142 TEMPLE STREET, SUITE 205
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Canaan Partners VII LLC
CENTRAL INDEX KEY: 0001514133
STATE OF INCORPORATION: CT
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36576
FILM NUMBER: 141018225
BUSINESS ADDRESS:
STREET 1: 285 RIVERSIDE AVENUE
STREET 2: STE. 250
CITY: WESTPORT
STATE: CT
ZIP: 06880
BUSINESS PHONE: 2038550400
MAIL ADDRESS:
STREET 1: 285 RIVERSIDE AVENUE
STREET 2: STE. 250
CITY: WESTPORT
STATE: CT
ZIP: 06880
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Canaan VII L P
CENTRAL INDEX KEY: 0001327625
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36576
FILM NUMBER: 141018226
BUSINESS ADDRESS:
STREET 1: C/O CANAAN MANAGEMENT INC
STREET 2: 105 ROWAYTON AVE
CITY: ROWAYTON
STATE: CT
ZIP: 06853
BUSINESS PHONE: 2038550400
MAIL ADDRESS:
STREET 1: C/O CANAAN MANAGEMENT INC
STREET 2: 105 ROWAYTON AVE
CITY: ROWAYTON
STATE: CT
ZIP: 06853
4
1
a4.xml
4
X0306
4
2014-08-05
0
0001267813
MARINUS PHARMACEUTICALS INC
MRNS
0001327625
Canaan VII L P
285 RIVERSIDE AVENUE
SUITE 250
WESTPORT
CT
06880
1
0
1
0
0001514133
Canaan Partners VII LLC
285 RIVERSIDE AVENUE
SUITE 250
WESTPORT
CT
06880
1
0
1
0
Common Stock
2014-08-05
4
C
0
1836398
A
1836398
I
See Footnote
Common Stock
2014-08-05
4
P
0
625000
8.00
A
2461398
I
See Footnote
Series A Preferred Stock
2014-08-05
4
C
0
4742516
D
Common Stock
729618
0
I
See Footnote
Series B Preferred Stock
2014-08-05
4
C
0
3838214
D
Common Stock
590494
0
I
See Footnote
Series C Preferred Stock
2014-08-05
4
C
0
3355859
D
Common Stock
516286
0
I
See Footnote
Warrants to Purchase Series B Preferred Stock
2014-08-05
4
J
0
959553
10.86
D
Common Stock
147624
0
I
See Footnote
Upon the closing of Issuer's initial public offering on August 5, 2014, the preferred stock, which has no expiration date and convertible at any time at the option of the holder, automatically converted, at a conversion ratio of one share of Common Stock for every 6.5 shares of preferred stock, for no additional consideration.
Shares held directly by Canaan VII L.P. (the "Canaan Fund"). Canaan Partners VII LLC ("Canaan VII" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Canaan VII disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of any pecuniary interest therein. Stephen Bloch, a manager of Canaan VII, serves as the representative of the Canaan Entities on the Issuer's board of directors.
This warrant was immediately exercisable. Upon the closing of Issuer's public offering, the warrant was cancelled automatically and for no value in accordance with its terms as it was out-of-the-money..
Canaan VII L.P. By: Canaan Partners VII LLC its General Partner /s/ Jaime Slocum Attorney-in-Fact
2014-08-05
Canaan Partners VII LLC By: /s/ Jaime Slocum Attorney-in-Fact
2014-08-05